Market Price Volatility and Impairment Risk for Investment Securities
First written in FY2021. 2 of 4 entries say "Mitigated", first in FY2025. Latest entry: FY2027-H1.
The whole theme swung hardest in 2019: 37 of 69 companies on the "Worse" side.
24 other companies' latest entry also says "Mitigated".
- FY2027-H1MitigatedAnnual report
「The gain on sales of investment securities resulted from the partial sale of cross-held shares.」
The partial sale of cross-shareholdings reduced the Company's exposure to investment securities and advanced its response to market-price fluctuation and impairment risks. - FY2025MitigatedAnnual report
「Equity securities for which the amount recognized on the consolidated balance sheet does not exceed acquisition cost ¥72.855 million ¥102.005 million △¥29.150 million」
Investment securities below acquisition cost amounted to ¥72.855 million, with a valuation difference of △¥29.150 million. The loss narrowed from the previous fiscal year's valuation difference of △¥30.977 million, and no impairment was recognized during the fiscal year. - FY2023MaterialisedAnnual report
「Equity securities for which the amount recognized on the consolidated balance sheet does not exceed acquisition cost ¥138.704 million ¥186.910 million △¥48.205 million」
Regarding market-price fluctuation risk, investment securities below acquisition cost amounted to ¥138.704 million at the end of the fiscal year, with a valuation difference of △¥48.205 million. Although no impairment was recognized, the impact of market-price fluctuations was quantified. - FY2021First statedAnnual report
「Investment securities consist mainly of shares in companies with which the Company has business relationships and are exposed to the risk of fluctuations in market prices. The Company determines their fair value on a quarterly basis in relation to this risk.」
The possibility that investment securities may require impairment due to market-price fluctuations and deterioration in the performance of investee companies was explicitly identified as a risk. During the fiscal year, the Company actually recognized a ¥87.495 million loss on valuation of investment securities.